NCT05709314View on ClinicalTrials.gov

A Study of AMDX-2011P in Participants With CAA

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Cerebral Amyloid Angiopathy
Interventions
DRUG

AMDX-2011P

AMDX-2011P single bolus injection intravenous for diagnostic review

Trial Locations (3)

85020

RECRUITING

Associated Retina Consultants, Phoenix

91204

RECRUITING

Global Research Management, Glendale

92663

RECRUITING

Eye Research Foundation, Newport Beach

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

Amydis Inc.

INDUSTRY